Federally Compliant Medical Cannabis In The US? One Company Is Doing It

CURE Pharmaceutical (OTC: CURR) has signed an agreement with Biopharmaceutical Research Company (BRC) to produce federally compliant , CBD and THC products.

BRC will provide the cannabinoid ingredients and CURE will use them to begin the development of CBD and THC oral thin films for CURE’s clinical studies targeted at advancing veteran health. 

This is BRC's first cannabis cultivation partnership since becoming licensed by the .

“For several years, CURE has been working to …

Full story available on Benzinga.com

More Federally Compliant Medical Cannabis In The US? One Company Is Doing It